Two decades ago, the Canadian CDMO BioVectra installed Heather Delage as its director of business development. She was named vice president of business development in 2014. In 2021, she assumed the role of chief commercial officer. At the outset of her tenure with BioVectra, the company was beginning its journey to invest in large-scale cGMP…
Why BioVectra has big mRNA biomanufacturing ambitions
Founded in 1970, BioVectra is a CDMO with specialties in microbial fermentation, complex chemistry and biologics. The company is looking to bolster its mRNA manufacturing capability. In November 2021, the Canadian company announced its intent to build a new $79.6 million facility dedicated to producing and manufacturing mRNA vaccines and therapeutics. The initiative resulted from…